Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
14.90
-0.30 (-1.97%)
At close: May 26, 2026, 4:00 PM EDT
14.82
-0.08 (-0.54%)
After-hours: May 26, 2026, 4:49 PM EDT
Mesoblast Market Cap
Mesoblast has a market cap or net worth of $1.93 billion as of May 26, 2026. Its market cap has increased by 46.81% in one year.
Market Cap
1.93B
Enterprise Value
1.94B
1-Year Change
46.81%
Ranking
Category
Stock Price
$14.90
Market Cap Chart
Since November 13, 2015, Mesoblast's market cap has increased from $593.20M to $1.93B, an increase of 225.42%. That is a compound annual growth rate of 11.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 1.96B | -15.18% |
| Dec 31, 2025 | 2.31B | 2.14% |
| Dec 31, 2024 | 2.26B | 1,162.26% |
| Dec 29, 2023 | 179.10M | -58.22% |
| Dec 30, 2022 | 428.70M | -31.15% |
| Dec 31, 2021 | 622.70M | -37.40% |
| Dec 31, 2020 | 994.70M | 35.19% |
| Dec 31, 2019 | 735.80M | 84.92% |
| Dec 31, 2018 | 397.90M | -27.59% |
| Dec 29, 2017 | 549.50M | 34.55% |
| Dec 30, 2016 | 408.40M | -12.21% |
| Dec 31, 2015 | 465.20M | -21.58% |
| Nov 13, 2015 | 593.20M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharvaris | 2.07B |
| Nanobiotix | 2.05B |
| Trevi Therapeutics | 2.01B |
| Aurinia Pharmaceuticals | 1.96B |
| Ascentage Pharma Group International | 1.96B |
| Tyra Biosciences | 1.93B |
| ADMA Biologics | 1.91B |
| Viridian Therapeutics | 1.90B |